Sarganas Giselle, Knopf Hildtraud, Grams Daniel, Neuhauser Hannelore K
Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Germany.
Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany;
Am J Hypertens. 2016 Jan;29(1):104-13. doi: 10.1093/ajh/hpv067. Epub 2015 May 11.
Hypertension is a major risk factor for morbidity and mortality, therefore its control is of great importance. In this study we compare the use of antihypertensive medication among adults with hypertension in Germany 1998 and 2008-2011 and determine factors associated with use and control.
Data from German Health Examination Surveys (GNHIES98 1998, n = 7,124 and DEGS1 2008-2011 n = 7,988, age 18-79 years) including standardized blood pressure (BP) measurements and Anatomical Therapeutic Chemical (ATC) medication codes were analyzed.
The use of antihypertensive medication among adults with hypertension in Germany increased from 54% to 72% in 1 decade. In 2008-2011, 67% of users were treated with polytherapy. The most commonly used antihypertensive class in 1998 was diuretics (43%) and in 2008-2011 beta-blockers (54%). Ramipril and metoprolol are currently the most commonly used monotherapy agents, while ramipril in combination with hydrochlorothiazide is the most frequent polytherapy. Being a woman, older age, having statutory health insurance, diabetes, coronary heart disease (CHD), stroke, and obesity were positively associated with antihypertensive use. The control rate among treated increased from 42% to 72%. Young women (18-54 years) had better control compared to older women or to men. Having CHD or stroke was positively associated with BP control.
Increased and improved antihypertensive use might be a main contributor to the decrease in BP observed in Germany in the last decade. However, there are still socio-demographic and health disparities in hypertension treatment and control.
高血压是发病和死亡的主要危险因素,因此对其进行控制至关重要。在本研究中,我们比较了1998年以及2008 - 2011年德国成年高血压患者的降压药物使用情况,并确定与使用及控制相关的因素。
分析来自德国健康检查调查(1998年的GNHIES98,n = 7124;2008 - 2011年的DEGS1,n = 7988,年龄18 - 79岁)的数据,包括标准化血压(BP)测量值和解剖治疗化学(ATC)药物编码。
在10年时间里,德国成年高血压患者的降压药物使用率从54%增至72%。2008 - 2011年,67%的使用者接受联合治疗。1998年最常用的降压药物类别是利尿剂(43%),2008 - 2011年是β受体阻滞剂(54%)。雷米普利和美托洛尔是目前最常用的单一疗法药物,而雷米普利与氢氯噻嗪联合使用是最常见的联合疗法。女性、年龄较大、拥有法定医疗保险、患有糖尿病、冠心病(CHD)、中风和肥胖与降压药物使用呈正相关。接受治疗者的控制率从42%增至72%。年轻女性(18 - 54岁)相比老年女性或男性,血压控制情况更好。患有冠心病或中风与血压控制呈正相关。
降压药物使用的增加及改善可能是过去十年德国观察到的血压下降的主要原因。然而,在高血压治疗和控制方面仍存在社会人口统计学和健康差异。